Please ensure Javascript is enabled for purposes of website accessibility
Acadia Pharmaceuticals Stock Quote

Acadia Pharmaceuticals (NASDAQ: ACAD)

$19.72
(-1.9%)
-$0.39
Price as of February 8, 2023, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Acadia Pharmaceuticals Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
ACAD -21.53% -30.24% -6.95% +194%
S&P -7.13% +61.33% +10.04% +271%

Acadia Pharmaceuticals Company Info

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

News & Analysis

The Fool has written over 200 articles on Acadia Pharmaceuticals.

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
415%
 
S&P 500 Returns
122%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 02/09/2023.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.